Cellerant
Navigation Links
Cellerant in Medical Technology
... led by Dr. Julie Christensen with
colleagues from cellerant and Stanford University, was published on
April 13...n of pure stem cells in
treating such diseases."
cellerant researchers worked with specialized mice that are
...rsus-host disease in donor-to-patient
transplants. cellerant is developing hematopoietic stem cells for
cancer,...
Cellerant in Biological News
NIAID announces 25 new awards to develop radiation countermeasures
...rges, M.D. Fred Hutchinson Cancer Research Center, Seattle, WA Andrei V. Gudkov, Ph.D., Cleveland Biolabs, Inc., Buffalo, NY Holger Karsunky, Ph.D., cellerant Therapeutics, Inc., San Carlos, CA Kathleen E. Rodgers, Ph.D., University of Southern California, Los Angeles In addition to the Project BioShiel...Cellerant in other areas
Products based on the regulation of the human haematopoietic (blood-forming) system. ... Cellerant Therapeutics announces dosing of first patient in a Phase 1 ...
Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant ... Cellerant researchers worked with specialized mice that are prone to an ...
Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant ... Cellerant researchers worked with specialized mice that are prone to an ...
Cellerant Therapeutics Awarded $13.5 Million Contract for Treatment of ...
Cellerant Therapeutics Awarded $13.5 Million Contract for Treatment of Acute Radiation Syndrome from the Biomedical Advanced Research and Development Authority ...Cellerant Therapeutics, Inc. Awarded $13.5 Million Contract for ...
... be used to move Cellerant's lead program, a human Myeloid ... Cellerant Therapeutics, Inc. • Biomedical Advanced Research and Development Authority (BARDA) ...Cellerant Therapeutics Announces Publication Confirming Activity of ...
Cellerant Therapeutics Announces Publication Confirming Activity of Myeloid Progenitor Cells in Mouse Model of Chemotherapy-Induced NeutropeniaCellerant Therapeutics Inc. - Company Profile - BioCentury
www.cellerant.com. Development Status. Preclinical (01/07/2007) ... Cellerant Therapeutics Inc. Completed. 05/11/2005. Venture (Series B financing) $25,000,000 ...Other TagsSciSciSciSciSciSciSciSciPuzzlPuzzlPractitionersPhilipOther Contentsporeporeporeporeporeporeporeporphyriawinewinewinewinewineportportportportportportportpostoperativepostoperativepostoperativepostoperative
WashesRaichurFinancesAgriculturalistJeopardizingScihushingneighboursPuzzlMiraculouslyPractitionersModernizeMorrisPhilip
(Date:11/30/2009)... CLEVELAND, Ohio, November 30 Sim...per of medical simulation systems, in collaboratio...Ocedure Rehearsal Studio(TM),workshop for the firs...Germany. , The Simbionix PROcedure Rehear...tor to enable clinicians to create practice scenar...
(Date:11/30/2009)...e-aged men and women who engage in high levels of ...e to their knees and increasing their risk for ost...at the annual meeting of the Radiological Society ...t people with higher physical activity levels may ...es and, thus, at higher risk for developing osteoa...
(Date:11/30/2009)...ge proportion of patients who undergo abdominal/pe...and unnecessary additional image acquisition resul...rding to a study presented today at the annual mee...(RSNA). , "It is the responsibility of all physi...hat the dosage is as low as reasonably achievable ...
(Date:11/30/2009)... 30, 2009 UT Southwestern Medical Center research...ies stave off complications associated with asthma...er issue of Pediatrics, suggest that interventio...dren who have received specialized topical trainin..., emergency room visits and missed adult workdays....
(Date:11/29/2009)... Moravia,s Nanjing-based Service Delivery...e , Brno, Czech Republic ...ion solution provider, is pleased to announce its ...2009, to be held in Nanjing, China, on November 30...nion-based companies that have established and gro...
Breaking Medicine News(10 mins):Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Too much physical activity may lead to arthritis 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2[0] Simbionix First Procedure Rehearsal Studio(TM) Training Workshop[0] Too much physical activity may lead to arthritis[0] Unindicated CT series result in unnecessary radiation exposure for patients[0] Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find[1] Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China
(Date:11/26/2009)...antlers, red deer have been caught in the hunters,...much more than decorative. They are lethal weapons...rey, from The University of York, UK, has been int...er half a century and has become fascinated by the...anding collaboration with Tomas Landete-Castillejo...
(Date:11/26/2009)... Staphylococcus Aureus ) and other drug-resistant ...e plasma prototype devices have been developed to ... cocktails. , Two prototype devices have been de... skin (e.g. hands and feet) in hospitals and publi...and another to shoot bacteria-killing agents into ...
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution 53788 1XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution 53788 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 1State Regulation of Massage Therapy Will Improve Public Health Safety 53783 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 1NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |